Edition:
United States

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

1.64USD
23 Apr 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.64
Open
$1.64
Day's High
$1.64
Day's Low
$1.64
Volume
1,704
Avg. Vol
2,537
52-wk High
$3.82
52-wk Low
$1.64

Chart for

About

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action,... (more)
No analyst recommendations are available for .

Overall

Beta: 0.25
Market Cap(Mil.): $8.12
Shares Outstanding(Mil.): 5.14
Dividend: --
Yield (%): --

Financials

  XTLB.OQ Industry Sector
P/E (TTM): -- 178.44 32.31
EPS (TTM): -0.25 -- --
ROI: -17.41 -0.73 12.97
ROE: -24.77 -2.77 14.84

Earnings vs. Estimates